Review Article

Distinct Roles of Wnt/β-Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis

Table 1

Wnt signaling involved in the pathogenesis of COPD and IPF.

DiseaseWnt signalingModelFunction/mechanismRef.

COPDWnt/β-catenin and PKC signalingHBEC cellsAn interaction of Wnt/β-catenin and PKC signaling reduced nicotine-induced surfactant protein A (SPA) SPD: surfactant protein D (SPD) in HBEC cells[49]
COPDWnt5BBEAS-2B and PBEC cellsAn exaggerated Wnt5B expression upon cigarette smoke exposure led to TGF-β/Smad3-dependent expression of genes related to airway remodeling in the bronchial epithelium of COPD patients[50]
COPDWnt/β-catenin3D cultures of murine and patient-derived lung tissue cultures (LTCs)Enhanced Wnt/β-catenin signaling using GSK3β
inhibitor LiCl and CHIR 99021 attenuated
pathological features of COPD patient-derived 3D-LTCs
[51]
COPDWnt/β-catenin signalingHuman primary pulmonary fibroblasts derived from non-COPD individualsWnt/β-catenin signaling contributes to ECM
production and differentiation pulmonary
fibroblasts by pulmonary fibroblasts
[47]
COPDWnt3a/β-catenin
signaling pathway
HBEC cellsWnt3a/β-catenin signaling promotes HBEC cells undergoing EMT upon nicotine stimulation in vitro[52]
COPDNoncanonical Wnt5B signalingHuman primary pulmonary fibroblasts
derived from COPD patients and
non-COPD individuals
Wnt5B induces IL-6 and CXCL8 secretion in pulmonary fibroblasts through FZD2 receptor and TAK1 signaling[53]
COPDWnt/β-catenin signalingHBEC cells, mouse lung tissues, and mouse modelsWnt/β-catenin has an essential role in airway
inflammation of COPD by PPARδ/p38 MAPK pathway,
a cigarette smoke reduced this signaling activation which
promotes inflammatory cytokine production in
airway epithelium
[54]
COPDWnt/β-catenin signalingMurine emphysema modelsA decreased Wnt/β-catenin signaling activity is involved in parenchymal tissue destruction and impaired repair capacity in lung of murine emphysema model[14]
COPDWnt/β-catenin signalingHuman lung epithelial cell lines and PBEC cellsWnt4 expression is downregulated in airway epithelial cells exposed to cigarette smoke extract (CSE), which in turn induces proinflammatory cytokine release of cells[55]
COPDFZD4, Wnt/β-catenin signalingLung tissues and primary AECII cells of COPD patients and smokers, mouse emphysema modelsReduced expression of FZD4 prevents Wnt/β-catenin-driven alveolar lung repair in COPD[56]
COPDWnt5AElastase and CS-induced COPD murine modelsAn inhibition of Wnt5A-mediated noncanonical Wnt signaling leads the attenuation of lung tissue destruction, improvement of lung function, and restoration of expression of Wnt/β-catenin signaling target genes in the elastase and CS-induced COPD models[46, 57]
COPDNoncanonical Wnt signalingFZD8-deficient mice, primary human
lung fibroblasts, and primary human
airway epithelial cells
FZD8 receptor is associated with chronic bronchitis
and is involved in cytokine secretion from human
pulmonary fibroblasts as well as acute CS-induced
inflammation in mice
[58]
IPFWnt/β-catenin
signaling and TGF-β
Pulmonary fibroblasts, bleomycin-induced pulmonary fibrosis murine modelAn inhibition of Wnt/β-catenin signaling by targeting Dvl leads an effective alleviation of fibrotic lung diseases in mice.[59]
IPFWnt/β-catenin, DKK1, DKK4Human bronchial and alveolar epithelial cell lines/bronchoalveolar tissuesDKK1 and DKK4 proteins are expressed in human IPF
lung epithelia; Wnt/β-catenin-induced epithelial cell
proliferation can be regulated by DKK1 in a
dose-dependent fashion
[60]
IPFWnt/β-catenin
signaling pathway
C57BL/6N miceBlockade of the Wnt/β-catenin signaling cascade
attenuates bleomycin-induced PF in mice
[61]
IPFWnt7BHuman lung tissue samplesWnt7B is expressed at high concentrations in regions of active hyperplasia, metaplasia, and fibrotic change of lungs in IPF patients[62]
IPFWnt10ABeomycin-induced mouse PF modelWnt10A activates TGF-β signaling, which plays an important role in the pathogenesis of IPF via TGF-β activation, suggesting it may be a sensitive predictor for the onset of human IPF[63]
IPFWnt/β-catenin
signaling, Wnt5A/B
Human diagnostic biopsies/donated lungsAn interaction between the inhibition of β-catenin
signaling and activation of Wnt5A/B is correlated
with aberrant nonfibrotic parenchyma in IPF lungs
[9]
IPFWnt5AIPF or UIP tissue sectionsA wide distribution of Wnt5A is expressed in cells of IPF lung, which can be significantly induced by Wnt7B and TGF-β1[64]
IPFWnt1inducible
signaling protein-1
(WISP1)
A mouse model of pulmonary fibrosis, AECII cellsWISP1 is a key regulator of AECII cell hyperplasia in pulmonary fibrosis of murine models[48]
IPFWnt/β-catenin/CREB binding protein (CBP) signalingBleomycin-induced lung fibrosis in miceICG-001 is selective blockade for β-catenin/CBP, which
shows ability to prevent fibrosis when it is concurrent
with bleomycin and reverse established fibrosis and
significantly improve survival of bleomycin-induced
lung fibrosis mice
[65]
IPFWnt/β-catenin signalingBleomycin-induced lung fibrosis miceWnt coreceptor, LRP5, is a genetic driver of lung fibrosis in bleomycin-induced lung fibrosis mice, which can be served as a marker of disease progression and severity in patients with IPF[66]
IPFWnt coreceptor LRP5Primary murine AECTII cellsRevealed that the alveolar epithelium is a relevant
source of proinflammatory cytokines induced by
active Wnt/β-catenin in pulmonary fibrosis
[67]
IPFWnt/β-catenin signalingA549 cell line and bleomycin-induced pulmonary fibrosis Sprague Dawley rat modelWnt/beta-catenin signaling activates TGF-beta/Smad2/3
signaling for myofibroblast proliferation in vitro
and in vivo
[68]
IPFWnt/β-catenin signalingHuman lung biopsies from IPF patients and non-IPF individualsSingle cell RNA-Seq revealed aberrant canonical Wnt signaling activation in IPF[69]
PFWnt/β-catenin signalingCoculture of BM-MSCs and AECII cells, NIH/3T3 fibroblastsWnt/β-catenin signaling inhibitor XAV939 is able to promote the differentiation of BM-MSCs into an epithelium-like phenotype in the coculture system, which also shows a capacity to inhibit the proliferation and myofibroblast differentiation of NIH/3T3 fibroblasts[61]
PFWnt/β-catenin signalingMLE-12 cellsRegulatory T-cell- (Treg-) promoted EMT of MLE-12 cells is mediated by Wnt/β-catenin signaling[70]
PFWnt/β-catenin signalingBleomycin-induced murine fibrotic lung tissue and primary AECII cellsAn inhibition of Wnt/β-catenin signaling suppressed the aberrant expression of TGF-β1 and FGF2 in bleomycin-induced murine fibrotic lung tissues and primary AECII cells, suggesting Wnt/β-catenin pathway can be served as a potential therapeutic strategy for PF[71]
PFWnt antagonists, SFRP1, and FRZBAlveolar epithelial cell line, lung fibroblast cell line, and bleomycin-induced lung fibrosis murine modelSFRP1 counteracts the effect of TGF-β1in pulmonary cells in vitro, but loss of neither SFRP1 nor FRZB alters fibrotic outcomes in the lungs in mice[72]
PFWnt/β-catenin signalingBALB/c miceAn upregulation of β-catenin and elevation of TGF-β1 are associated with PTX-mediated transformation of pulmonary emphysema into pulmonary fibrosis under chronic a CS exposure[73]
PFWnt/β-catenin signalingHCl-induced acute lung injury SD ratsThe aberrant activation of Wnt/β-catenin signaling induces the myofibroblast differentiation of engrafted MSCs in HCl-induced acute lung injury SD rats[74]
PFWnt/β-catenin signalingPrimary lung microvascular endothelial cells, bleomycin-induced lung fibrosis miceRepeated systemic administrations disrupt a normally fine-tuned balance in the Wnt signaling and induce reactive oxygen species (ROS) to cause DNA damage and fibrosis partially be affecting the endothelial niche[75]
PFLRP5, Wnt/β-catenin signalingBleomycin-induced lung fibrosis mice, LRP5-deficient miceLRP5/β-catenin signaling controls alveolar macrophage differentiation and inhibits resolution of pulmonary fibrosis[76]
PFWnt/β-catenin signalingHuman IMR-90 lung fibroblast cellsTGF-β1 can activate Wnt/β-catenin signaling pathway[77]

3D-LTCs: three-dimensional lung tissue cultures; AEC II: alveolar epithelial cell type II; ASM: airway smooth muscle; APC: adenomatous polyposis coli; BALF: bronchoalveolar lavage fluid; BM-MSCs: bone marrow-derived mesenchymal stem cells; CBP: CREB-binding protein; COPD: chronic obstructive pulmonary disease; CS: cigarette smoke; CSE: cigarette smoke extract; CTGF: connective tissue growth factor; CXCL: chemokine (C-X-C motif) ligand; DAAM1: dishevelled associated activator of morphogenesis 1; DKK: Dickkopf; Dvl: disheveled; ECM: extracellular matrix; EMMPRIN: extracellular matrix metalloproteinase inducer; EMT: epithelial-mesenchymal transition; FEV1: forced expiratory volume in 1 second; FGF: fibroblast growth factor; FRZB: frizzled-related protein; FZD: frizzled; GSK: glycogen synthase kinase; HBECs: human bronchial epithelial cells; hBSMC: human bronchial smooth muscle cell; IL: interleukin; IPF: idiopathic pulmonary fibrosis; JNK: c-Jun N-terminal protein kinases; LRP: low-density lipoprotein-related receptor; MLE: mouse lung epithelial; MMP: matrix metalloproteinase; NFAT: nuclear factor of activated T-cells; NF-κB: nuclear factor-κB; NLK: nemo-like kinase; PBEC: primary bronchial epithelial cell; PBMC: peripheral blood mononuclear cell; PF: pulmonary fibrosis; PKC: protein kinase C; PSMCs: parabronchial smooth muscle cells; PTX: pentoxifylline; Ror: receptor tyrosine kinase-like orphan receptor; RYK: receptor-like tyrosine kinase; SD: Sprague Dawley; SFRP1: secreted frizzled-related protein-1; shRNA: short hairpin RNA; siRNA: small interfering RNA; SMA: smooth muscle actin; SPA: surfactant protein A; SPD: surfactant protein D; TAK1: transforming growth factor-β activated kinase-1; TCF/LEF1: T-cell factor/lymphoid enhancer factor 1; TGF-β: transforming growth factor-beta; TNFα: tumor necrosis factor α; Th2: helper 2 T-cells; UIP: usual interstitial pneumonia; WIF1: Wnt inhibitory factor 1; WISP1: Wnt1 inducible signaling pathway protein-1; Wnt: wingless-type MMTV integration site.